Selected Research Publications:

 

3D Models of Neurodegenerative Diseases:

 

Functional bioengineered tissue models of neurodegenerative diseases.
Mullis and Kaplan. Biomaterials 298: 122143 (2023).

 

A long-living bioengineered neural tissue platform to study neurodegeneration.
Rouleau et al. Macromol Biosci 20: e2000004 (2020).

 

A 3D human brain-like tissue model of herpes-induced Alzheimer’s disease.
Cairns et al. Sci Adv 6: eaay8828 (2020).

 

Functional and sustainable 3D human neural network models from pluripotent stem cells.
Cantley et al. ACS Biomater Sci Eng 4: 4278 (2018).

 

Alzheimer’s Disease and other dementias:

 

Potential Involvement of Varicella Zoster Virus in Alzheimer’s Disease via Reactivation of Quiescent Herpes Simplex Virus Type 1.
Cairns et al. J Alzheimers Dis 88: 1189 (2022).

 

Screening neuroprotective compounds in herpes-induced Alzheimer’s disease cell and 3D tissue models.
Silveira et al. Free Radic Biol Med. 186: 76 (2022).
 
BACE1 elevation engendered by GGA3 deletion increases β-amyloid pathology in association with APP elevation and decreased CHL1 processing in 5XFAD mice.
Kim et al. Mol Neurodegener. 13: 6 (2018).

 

Inhibition of microglial activation protects hippocampal neurogenesis and improves cognitive deficits in a transgenic mouse model for Alzheimer’s disease.
Biscaro et al. Neurodegener Dis. 9: 187 (2012).

 

Mechanisms of enzymatic degradation of amyloid β microfibrils generating nanofilaments and nanospheres related to cytotoxicity.
Numata and Kaplan. Biochemistry 49: 3254 (2010).

 

Parkinson’s Disease:

 

3D biocomposite culture enhances differentiation of dopamine-like neurons from SH-SY5Y cells: A model for studying Parkinson’s disease phenotypes.
Fiore et al. Biomaterials 290: 121858 (2022).

 

Bioengineered models of Parkinson’s disease using patient-derived dopaminergic neurons exhibit distinct biological profiles in a 3D microenvironment
Fiore et al. Cell Mol Life Sci 79: 78 (2022).

 

Impaired dopamine release and synaptic plasticity in the striatum of parkin-/- mice.
Kitada et al. J Neurochem 110: 613 (2009).

 

R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice.
Tong et al. PNAS 106: 14622 (2009).

 

Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice.
Kitada et al. PNAS 104: 11441 (2007).